Short answer
Tenaya Therapeutics Inc (TNYA) filed an 8-K current report with the SEC on June 29, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Eric Hyllengren becomes CFO, Principal Financial Officer and Principal Accounting Officer July 13, 2026.
Tenaya Therapeutics Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Eric Hyllengren becomes CFO, Principal Financial Officer and Principal Accounting Officer July 13, 2026
- Leadership transition removes interim finance duties from CEO Faraz Ali and SVP Finance Tomohiro Higa
- Annual salary $490,000, with target bonus equal to 40% of base salary
- Proposed inducement option for 1,650,000 shares, subject to board approval and four-year vesting
- Option term 10 years, with exercise price set at grant-date fair market value
Item 7.01 · Regulation FD Disclosure
- Appointment of Mr. Hyllengren as Chief Financial Officer, signaling a change in financial leadership
- New CFO likely responsible for capital planning, reporting, and investor communications
- Exhibit 99.1 contains the appointment announcement and accompanying details
Item EX-99.1 · Exhibit EX-99.1
- Eric Hyllengren appointed CFO effective July 13, 2026, overseeing capital allocation, investor relations and corporate development
- Leadership change arrives as Tenaya advances genetic medicines toward pivotal clinical trials
- Hyllengren brings more than two decades of biotechnology finance and strategic experience
- Prior Atara role included executing more than $500 million in public financings
- Finance SVP Hiro Higa retiring in third quarter 2026, remaining as consultant for transition support
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Tenaya Therapeutics Inc 8-K filings
Get the next TNYA 8-K as it lands
Follow TNYA for push alerts, or ask the research agent what this filing means.